Skip to main content
UniHealth

Doctor search

Samuel Brusca, MD

Cardiovascular Disease (Cardiology) · San Francisco

NPI 1174942148

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
3
1 carrier
Offices
2
Since medical school
12 years
New York University School of Medicine, 2014

Offices

2 locations · Regents of the University of California · University of California San Francisco

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brusca’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A168461 · Current

Licensed to practise in California · since 2020 · expires 2028-04-30 · New York University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Cardiovascular Disease
  • American Board of Internal Medicine - Critical Care Medicine
  • American Board of Internal Medicine - Internal Medicine

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$104,487

Medicare paid this office $104,487 for 220 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Critical care, first 30-74 minutes132$70,482$182
Critical care, each additional 30 minutes56$12,530$92
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$3,785$105
Long return visit (40+ min)20$3,759$125
New patient visit (60+ min)15$1,972$131
See all 10 services
Every Original Medicare service billed
Critical care, first 30-74 minutes132$70,482$182
Critical care, each additional 30 minutes56$12,530$92
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$3,785$105
Long return visit (40+ min)20$3,759$125
New patient visit (60+ min)15$1,972$131
Insertion of non-tunneled central venous tube for infusion (5 years or older)18$1,315$69
Insertion of tube in pulmonary artery for monitoring14$1,030$74
Insertion of artery tube for blood sampling or infusion through skin24$970$37
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or14$727$27
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's32$698$14

Procedures Medicare counted

Procedure volume Medicare published
Pacemaker insertion or repair1-10None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure20192020202220232024
Insertion of artery tube for blood sampling or infusion through skin–––1726
Insertion of non-tunneled central venous tube for infusion (5 years or older)–––1519

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

220 Original Medicare patients in 2024. Average age 71 · Under 65 20% · 85 and older 10% · Women 40% · Also on Medicaid 51% · Health risk score 3.34. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Heart failure 75% · Chronic kidney disease 70% · Coronary heart disease 69% · Atrial fibrillation 62% · Diabetes 54% · COPD 38% · Depression 33% · Stroke 29% · Cancer 16% · Dementia 15%.

The office billed $854,637, Medicare allowed $132,823 and paid $104,487; for 810 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024220810713.34$854,637$104,487
2023140552722.97$712,021$85,846
20223697692.22$105,823$13,495
20202741792.36$21,044$6,832
20193851762.77$26,640$8,722

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Critical care, first 30-74 minutes102$68,738$185
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes32$3,691$103
Critical care, each additional 30 minutes15$2,229$93
Insertion of non-tunneled central venous tube for infusion (5 years or older)12$1,073$72
Insertion of tube in pulmonary artery for monitoring11$817$74
Insertion of artery tube for blood sampling or infusion through skin16$639$38

2022: 2 services

Original Medicare services billed in 2022
Critical care, first 30-74 minutes20$9,038$188
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes17$2,511$90

2020: 1 service

Original Medicare services billed in 2020
Critical care, first 30-74 minutes23$6,075$196

2019: 1 service

Original Medicare services billed in 2019
Critical care, first 30-74 minutes34$7,570$194

Medicaid work

$60,065 in 2024

Medicaid paid $60,065 for 334 billed services this clinician did in 2024, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes334$60,065
Medicaid work by year
2024334120$60,065
2023151116$18,552
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes151$18,552

Drugs they prescribed that Part D paid

$561,528

Pharmacies billed $561,528 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 134) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

91 generic and 43 brand-name prescriptions · $561,528 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Uptravi12$315,550$26,296
Jardiance11$16,382$1,489
Tadalafil15$11,461$764
Furosemide28$149$5
Spironolactone27$124$5
See all 6 drugs
Every Part D drug this clinician prescribed
Uptravi12$315,550$26,296
Jardiance11$16,382$1,489
Tadalafil15$11,461$764
Furosemide28$149$5
Spironolactone27$124$5
Atorvastatin12$73$6

Year by year

Part D prescribing by year
2024134230% (0)32%$561,528
202324None0% (0)None$4,753
201714235NoneNone$25,699
201654383None21%$49,635
2015378926% (21)None$49,970
20148722NoneNone$3,932

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 1 drug

Part D drugs prescribed in 2023
Furosemide13$48$4

2017: 1 drug

Part D drugs prescribed in 2017
Amlodipine Besylate22$114$5

2016: 15 drugs

Part D drugs prescribed in 2016
Humalog Kwikpen U-10012$5,685$474
Atrovent Hfa12$3,586$299
Metoprolol16$378$24
Atorvastatin34$371$11
Lidocaine-Prilocaine11$358$33
Labetalol16$333$21
Latanoprost13$255$20
Pantoprazole27$236$9
Lisinopril30$185$6
Montelukast12$101$8
Losartan14$95$7
Ranitidine12$75$6
Amlodipine Besylate20$68$3
Furosemide22$63$3
Fluticasone Propionate13$54$4

2015: 8 drugs

Part D drugs prescribed in 2015
Metoprolol12$392$33
Oxycodone11$283$26
Levothyroxine12$256$21
Fluticasone Propionate17$214$13
Lisinopril53$214$4
Atorvastatin16$199$12
Montelukast11$161$15
Amlodipine Besylate18$94$5

2014: 1 drug

Part D drugs prescribed in 2014
Lisinopril13$84$6

Money from drug and device companies

$3,039 in 2025

Industry payments by year
2025410$2,695$3,039
202411None$125
202311None$96

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Actelion Pharmaceuticals USUptravi$2,817
5 payments
  • Meals for Uptravi · 2025-05-17 · $55
  • Travel for Uptravi · 2025-05-17 · $23
  • Consulting for Uptravi · 2025-05-17 · $2,695
  • Meals for Uptravi · 2025-05-17 · $19
  • Travel for Uptravi · 2025-05-17 · $25
AbiomedNone$119
2 payments
  • Meals · 2025-09-22 · $57
  • Meals · 2025-09-16 · $62
Merck Sharp & DohmeNone$85
2 payments
  • Meals · 2025-05-21 · $41
  • Meals · 2025-03-30 · $44
AngioDynamicsAlphavac$17
1 payment
  • Meals for Alphavac · 2025-05-09 · $17
See all 10 published payments
Every published payment
AbiomedMeals · 2025-09-22None$57
AbiomedMeals · 2025-09-16None$62
Merck Sharp & DohmeMeals · 2025-05-21None$41
Actelion Pharmaceuticals USMeals · 2025-05-17Uptravi$55
Actelion Pharmaceuticals USTravel · 2025-05-17Uptravi$23
Actelion Pharmaceuticals USConsulting · 2025-05-17Uptravi$2,695
Actelion Pharmaceuticals USMeals · 2025-05-17Uptravi$19
Actelion Pharmaceuticals USTravel · 2025-05-17Uptravi$25
AngioDynamicsMeals · 2025-05-09Alphavac$17
Merck Sharp & DohmeMeals · 2025-03-30None$44
See earlier years (2024, 2023)

2024: $125

Payments by company in 2024
Actelion Pharmaceuticals USNone$125
1 payment
  • Meals · 2024-09-20 · $125

2023: $96

Payments by company in 2023
Merck Sharp & DohmeNone$96
1 payment
  • Meals · 2023-05-10 · $96

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Actelion Pharmaceuticals US, Inc. · Slp-C-23-USA-008-V01 · 2024Their institution$138,228
Actelion Pharmaceuticals US, Inc. · A Team-Based Patient Engagement Approach To Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension · 2025Their institution$49,501
Janssen Scientific Affairs, LLC · Slp-C-23-USA-008-V01 · 2024Their institution$11,248

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1174942148
Licence
CA A168461California A168461: Current · expires 2028-04-30
Trained
New York University School of Medicine, 2014 · 12 years ago
Group
Regents of the University of California · University of California San Francisco
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Cardiology (207RC0000X)
Mailing address
505 Parnassus Ave Rm M1182a, San Francisco, CA, 94143
NPI first listed
2014-04-07
NPI last updated
2025-12-04
NPI record certified
2025-12-04

This is when the NPI record was last certified, not a medical board exam.